NCT02071212View on ClinicalTrials.gov

Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Coronary Artery Disease
Interventions
DRUG

Ticagrelor

Loading dose 180 mg . Maintainance dose 90 mg BID

Trial Locations (1)

Unknown

Ippokratio Hospital, Athens

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Hellenic Cardiovascular Research Society

OTHER